Naltrexone in the Treatment of Trichotillomania



Status:Archived
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:August 2008
End Date:December 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Double-blind, Placebo-controlled Study of Naltrexone in Trichotillomania


This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania


The goal of the proposed study is to evaluate the efficacy of Naltrexone in
trichotillomania. Forty subjects with DSM-IV trichotillomania will receive 8 weeks of
double-blind Naltrexone or placebo. The hypothesis to be tested is that Naltrexone will be
effective and well tolerated in patients with trichotillomania compared to placebo. The
proposed study will provide needed data on the treatment of a disabling disorder that
currently lacks a clearly effective treatment.


We found this trial at
1
site
University of Minnesota Medical Center
2450 Riverside Avenue
Minneapolis, Minnesota 55455
(612) 273-3000
University of Minnesota Medical Center Improving patients' lives drives the innovation that makes University of...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials